跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METHOTREXATE TABLETS, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
METHOTREXATE TABLETS, USP
Authorized
STANDARD
METHOTREXATE TABLETS, USP
Pfizer Canada Ulc
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
27723c2eeb2668e9
Company
Pfizer Canada Ulc
Type
Standard
Approval Details
Approval Id
27723c2eeb2668e9
Drug Approval Canada Name
METHOTREXATE TABLETS, USP
Product Name
METHOTREXATE TABLETS, USP
Status
Approved
Status Date
2025-12-05
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BA01 METHOTREXATE
Aig Number
0107545004
Company Name
Pfizer Canada Ulc
Company Address
17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5
Company Detail Path
/organization/pfizer-canada-ulc
Company Information
Pharmaceutical Company Name
Pfizer Canada Ulc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
17300 rte Transcanadienne
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
27723c2eeb2668e9
Type
Standard
Back to Health Canada Approvals